Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SHOP APOTHEKE EUROPE N.V.

(SAE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

SHOP APOTHEKE EUROPE N : PUBLISHES AGENDA ANNUAL GENERAL MEETING OF SHAREHOLDERS 2021.á

03/10/2021 | 03:38pm EDT

DGAP-News: SHOP APOTHEKE EUROPE N.V. / Key word(s): AGM/EGM
SHOP APOTHEKE EUROPE N.V. PUBLISHES AGENDA ANNUAL GENERAL MEETING OF SHAREHOLDERS 2021. 

10.03.2021 / 21:35
The issuer is solely responsible for the content of this announcement.


NOT FOR DIRECT OR INDIRECT RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES OF AMERICA, CANADA, SOUTH AFRICA, AUSTRALIA OR JAPAN.

SHOP APOTHEKE EUROPE N.V. PUBLISHES AGENDA ANNUAL GENERAL MEETING OF SHAREHOLDERS 2021. 

Venlo, 10 March2021. SHOP APOTHEKE EUROPE N.V. ("SHOP APOTHEKE EUROPE" or the "Company") has today published the agenda for the annual general meeting of shareholders of the Company (the "AGM") to be held virtually on 21 April 2021. The convocation announcement and the agenda, the accompanying explanatory notes and other information/documentation are available on the corporate website of the Company (http://shop-apotheke-europe.com) under Investor Relations / General Meeting / Annual General Meeting 2021 and via the link

http://shop-apotheke-europe.com/en/investorrelations/hauptversammlung/

The AGM will take place on 21 April 2021 starting at 10:00 CEST, and will take place fully virtually this year on the basis of the Dutch Temporary Law Covid-19 Justice and Safety (the "Emergency Law"). The Company believes that a virtual meeting is the most prudent decision in view of the ongoing Covid-19 pandemic and considering the current guidelines of the Dutch government regarding the Covid-19 pandemic. This means that no visitors or shareholders can attend the meeting in person. The Company's shareholders, who are entitled to participate and exercise voting rights, can take part in the annual general meeting via the webcast on 21 April 2021 and can vote virtually during the meeting, in each case via an online platform provided by the Company's service provider for annual general meetings (such online platform, the "Virtual AGM Platform"). Furthermore, shareholders can ask questions either during the meeting and/or prior to the date of the meeting. The terms and conditions regarding virtual general meetings are available on the virtual AGM platform and apply to all shareholders who wish to attend, participate and vote at the meeting via the Virtual AGM Platform. Please refer to Section 3 (General Information) of the convocation announcements for further details regarding how to submit questions, attend, participate and vote at the AGM via the Virtual AGM Platform.

Should the Emergency Law no longer apply on 21 April 2021, the Company will not be able to hold the annual general meeting fully virtually and, therefore, the annual general meeting will then take place on the same date and at the same time both virtually via the virtual AGM Platform and with limited access in person at Dirk Hartogweg 14, 5928 LV Venlo (such meeting, the "Hybrid Meeting"). In the event that the annual general meeting must be held in the form of the Hybrid Meeting, the Company urges all its shareholders to carefully consider whether they wish to attend the annual general meeting in person at the venue in Venlo in view of possible health risks relating to the ongoing Covid-19 pandemic. The Company gives top priority to the health of its employees, shareholders and other stakeholders and, therefore, the Company strongly encourages its shareholders to take part in the annual general meeting via the webcast on 21 April 2021 and vote virtually during the meeting, in each case via the Virtual AGM Platform, and not to attend the Hybrid Meeting in person. This way, the Hybrid Meeting can take place with only a limited number of core attendees and health risks for those attendees can be limited as much as possible. If the annual general meeting this year will need to be held in the form of the Hybrid Meeting, the Company will announce that on the Company's corporate website before 21 April 2021.


For further information please contact us at:

General AGM related matters:
Rens Jan Kramer
Telephone: +31 6 46 18 67 23
Email: rensjan.kramer@shop-apotheke.com

Trade and public media:
Sven Schirmer
Mobile: +49 152 28 50 63 61
Email: presse@shop-apotheke.com

Financial media:
Thomas Schnorrenberg
Mobile: +49 151 46 53 13 17
Email: presse@shop-apotheke.com



10.03.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: SHOP APOTHEKE EUROPE N.V.
Dirk Hartogweg 14
5928 LV Venlo
Netherlands
Phone: 0800 - 200 800 300
Fax: 0800 - 90 70 90 20
E-mail: carmen.herkenrath@shop-apotheke.com
Internet: www.shop-apotheke-europe.com
ISIN: NL0012044747, DE000A19Y072
WKN: A2AR94, A19Y07
Indices: MDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1174735

 
End of News DGAP News Service

1174735  10.03.2021 

fncls.ssp?fn=show_t_gif&application_id=1174735&application_name=news&site_id=zonebourse_sftp

ę EQS 2021
All news about SHOP APOTHEKE EUROPE N.V.
09/22SHOP APOTHEKE EUROPE NV : Berenberg reiterates its Buy rating
MD
09/20SHOP APOTHEKE EUROPE N.V.(XTRA : SAE) added to Germany SDAX (Total Return) Index
CI
09/17SHOP APOTHEKE EUROPE N.V.(XTRA : SAE) dropped from Germany MDAX Index (Performance)
CI
09/16SHOP APOTHEKE EUROPE : Move to Next Generation Logistics Centre Completed.
EQ
09/16PRESS RELEASE : SHOP APOTHEKE EUROPE: Move to Next Generation Logistics Centre Completed.
DJ
09/14SHOP APOTHEKE EUROPE NV : Kepler Cheuvreux keeps a Sell rating
MD
09/01SHOP APOTHEKE EUROPE NV : Buy rating from Jefferies
MD
08/11DGAP-DD : SHOP APOTHEKE EUROPE N.V. english
DJ
08/09SHOP APOTHEKE EUROPE NV : Buy rating from Baader Bank
MD
08/06SHOP APOTHEKE EUROPE NV : Deutsche Bank gives a Buy rating
MD
More news
Analyst Recommendations on SHOP APOTHEKE EUROPE N.V.
More recommendations
Financials
Sales 2021 1 106 M 1 296 M 1 296 M
Net income 2021 -30,1 M -35,3 M -35,3 M
Net Debt 2021 24,6 M 28,8 M 28,8 M
P/E ratio 2021 -81,2x
Yield 2021 -
Capitalization 2 479 M 2 903 M 2 905 M
EV / Sales 2021 2,26x
EV / Sales 2022 1,74x
Nbr of Employees 1 211
Free-Float 97,8%
Chart SHOP APOTHEKE EUROPE N.V.
Duration : Period :
Shop Apotheke Europe N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SHOP APOTHEKE EUROPE N.V.
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 11
Last Close Price 137,00 €
Average target price 193,45 €
Spread / Average Target 41,2%
EPS Revisions
Managers and Directors
Stefan Feltens Chief Executive Officer
Jasper Eenhorst Chief Financial Officer
Bj÷rn H. S÷der Chairman-Supervisory Board
Marc Fischer Chief Information Officer
Theresa Holler Chief Operating Officer
Sector and Competitors